MML Investors Services’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.09M Sell
18,706
-2,355
-11% -$515K 0.01% 885
2025
Q1
$4.72M Buy
21,061
+819
+4% +$183K 0.02% 750
2024
Q4
$6.63M Buy
20,242
+1,725
+9% +$565K 0.02% 596
2024
Q3
$5.56M Buy
18,517
+437
+2% +$131K 0.02% 644
2024
Q2
$5.96M Buy
18,080
+3,135
+21% +$1.03M 0.02% 587
2024
Q1
$5.91M Sell
14,945
-1,407
-9% -$557K 0.02% 571
2023
Q4
$5.76M Buy
16,352
+3,157
+24% +$1.11M 0.03% 542
2023
Q3
$4.95M Buy
13,195
+662
+5% +$248K 0.03% 541
2023
Q2
$4.79M Buy
12,533
+678
+6% +$259K 0.03% 552
2023
Q1
$4.11M Sell
11,855
-482
-4% -$167K 0.03% 526
2022
Q4
$2.9M Sell
12,337
-5,875
-32% -$1.38M 0.02% 677
2022
Q3
$4.48M Sell
18,212
-1,486
-8% -$366K 0.03% 475
2022
Q2
$5.96M Sell
19,698
-2,854
-13% -$863K 0.05% 372
2022
Q1
$9.26M Buy
22,552
+2,429
+12% +$998K 0.07% 294
2021
Q4
$9.44M Buy
20,123
+1,826
+10% +$856K 0.07% 286
2021
Q3
$7.77M Buy
18,297
+260
+1% +$110K 0.06% 310
2021
Q2
$6.48M Buy
18,037
+2,229
+14% +$800K 0.05% 336
2021
Q1
$4.45M Buy
15,808
+3,286
+26% +$926K 0.04% 395
2020
Q4
$3.55M Buy
12,522
+1,291
+11% +$366K 0.04% 402
2020
Q3
$3.09M Buy
11,231
+334
+3% +$91.8K 0.04% 382
2020
Q2
$2.48M Buy
10,897
+3,592
+49% +$816K 0.03% 429
2020
Q1
$1.11M Buy
7,305
+1,551
+27% +$236K 0.02% 591
2019
Q4
$865K Buy
5,754
+566
+11% +$85.1K 0.01% 766
2019
Q3
$736K Buy
5,188
+324
+7% +$46K 0.01% 804
2019
Q2
$609K Buy
4,864
+1,141
+31% +$143K 0.01% 926
2019
Q1
$410K Buy
3,723
+17
+0.5% +$1.87K 0.01% 1108
2018
Q4
$363K Buy
3,706
+694
+23% +$68K 0.01% 1074
2018
Q3
$372K Buy
+3,012
New +$372K 0.01% 1168